Work

The induction of RANKL molecule clustering could stimulate early osteoblast differentiation

Year: 2018

Type: article

Source: Biochemical and Biophysical Research Communications

DOI: 10.1016/j.bbrc.2018.12.093

Authors: Eri Sone, Daisuke Noshiro, Yuki Ikebuchi, Mami Nakagawa, Masud Khan, Yukihiko Tamura, Masaomi Ikeda, Meiko Oki, Ramachandran Murali, Toshihiko Fujimori, Tetsuya Yoda, Masashi Honma, Hiroshi Suzuki, Toshio Ando, Kazuhiro Aoki

Institutions: Tokyo Medical and Dental University, Kanazawa University, Nano Life Science Institute, Kanazawa University, University of Tokyo Hospital, The University of Tokyo, National Institute for Basic Biology, Cedars-Sinai Medical Center

Language: English

Topic: Bone Metabolism and Diseases

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Japan Society for the Promotion of Science

Awards: Analysis on the pharmacological mechanism of W9 peptide and development for the novel drug based on the strong potential for chondrocyte differentiation, Advanced Bioimaging Support, Development of a revolutionary bone anabolic reagent by optimizing the RANKL reverse signaling to stimulate bone formation., G372004903, Analyses of crosstalk between RANKL reverse signaling and Wnt signaling pathways in osteoblasts, The therapeutic applications of RANKL working as a bone-formation-stimulating receptor, A new drug development for accelerating bone and/or cartilage formation by RANK-like peptide

OpenAlex ID: W2906550673

FWCI: 0.793

Cites: 25

Cited by: 24

Related to: 10